Market Overview

Recap: Humana Q2 Earnings


Shares of Humana (NYSE:HUM) moved higher by 1.2% in pre-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share were up 107.60% over the past year to $12.56, which beat the estimate of $10.27.

Revenue of $19,083,000,000 up by 17.47% year over year, which beat the estimate of $18,630,000,000.

Looking Ahead

The upcoming fiscal year's EPS expected to be between $18.25 and $18.75.

How To Listen To The Conference Call

Date: Aug 05, 2020

Time: 09:00 AM

ET Webcast URL:

Recent Stock Performance

52-week high: $412.70

52-week low: $208.25

Price action over last quarter: Up 3.64%

Company Overview

Humana is one of the largest private insurance health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services and pharmacy benefit management.


Related Articles (HUM)

View Comments and Join the Discussion!

Posted-In: Earnings News

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at